North America remains the largest contributor to the global exosomes market, driven by substantial R&D investments, expanding clinical trials, and strong collaborations between biotechnology companies ...
It's not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring.
Veralto Announces Agreement to Acquire In-Situ and Establishes $750 Million Share Repurchase Program
WALTHAM, Mass., Nov. 25, 2025 /PRNewswire/ -- Veralto (NYSE: VLTO) (the "Company"), a global leader in essential water and product quality solutions dedicated to Safeguarding the World's Most Vital ...
Department of Biology, San Diego State University, United States; Center for Computational Biology and Bioinformatics, University of California, San Diego, United States; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback